Total Payments
$3,091
2024 Payments
$218.72
Companies
10
Transactions
21
Medicare Patients
1,120
Medicare Billing
$235,597
Payment Breakdown by Category
Travel$1,948 (63.0%)
Food & Beverage$1,142 (37.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,948 | 4 | 63.0% |
| Food and Beverage | $1,142 | 17 | 37.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $1,672 | 7 | $0 (2017) |
| Clovis Oncology, Inc. | $601.03 | 4 | $0 (2018) |
| CLINIGEN, INC. | $302.40 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $142.50 | 2 | $0 (2024) |
| PFIZER INC. | $135.00 | 1 | $0 (2024) |
| Array BioPharma Inc. | $97.24 | 1 | $0 (2019) |
| Immunocore Limited | $61.98 | 1 | $0 (2023) |
| EMD Serono, Inc. | $32.23 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $23.77 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $22.74 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $218.72 | 4 | PFIZER INC. ($135.00) |
| 2023 | $199.50 | 3 | Novartis Pharmaceuticals Corporation ($113.75) |
| 2022 | $157.40 | 1 | CLINIGEN, INC. ($157.40) |
| 2019 | $242.24 | 2 | Clinigen Inc ($145.00) |
| 2018 | $601.03 | 4 | Clovis Oncology, Inc. ($601.03) |
| 2017 | $1,672 | 7 | Merck Sharp & Dohme Corporation ($1,672) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/02/2024 | PFIZER INC. | LORBRENA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Oncology | ||||||
| 03/06/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Oncology | ||||||
| 01/25/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $32.23 | General |
| 10/27/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $113.75 | General |
| 09/19/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.77 | General |
| 02/08/2023 | Immunocore Limited | KIMMTRAK (Drug) | Food and Beverage | In-kind items and services | $61.98 | General |
| Category: Oncology | ||||||
| 11/11/2022 | CLINIGEN, INC. | PROLEUKIN (Drug) | Food and Beverage | Cash or cash equivalent | $157.40 | General |
| Category: METASTATIC RENAL CELL CARCINOMA OR MELANOMA | ||||||
| 12/17/2019 | Clinigen Inc | Proleukin (Drug) | Food and Beverage | In-kind items and services | $145.00 | General |
| Category: Metastatic Renal Cell Carcinoma or Melanoma | ||||||
| 06/01/2019 | Array BioPharma Inc. | — | Food and Beverage | In-kind items and services | $97.24 | General |
| 06/11/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $455.96 | General |
| Category: Oncology | ||||||
| 06/11/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: Oncology | ||||||
| 06/11/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $52.44 | General |
| Category: Oncology | ||||||
| 06/11/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Oncology | ||||||
| 07/07/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Travel and Lodging | Cash or cash equivalent | $32.39 | General |
| Category: ONCOLOGY | ||||||
| 06/23/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: ONCOLOGY | ||||||
| 06/23/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: ONCOLOGY | ||||||
| 06/23/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $1,260.79 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $199.15 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $94.77 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 339 | 661 | $213,882 | $72,977 |
| 2022 | 6 | 275 | 541 | $179,883 | $62,380 |
| 2021 | 6 | 304 | 656 | $198,482 | $73,244 |
| 2020 | 6 | 202 | 413 | $87,482 | $26,997 |
Total Patients
1,120
Total Services
2,271
Medicare Billing
$235,597
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 144 | 422 | $145,968 | $51,624 | 35.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 58 | 58 | $28,218 | $8,818 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 63 | $16,029 | $4,646 | 29.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $14,073 | $4,478 | 31.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 56 | 67 | $5,590 | $1,860 | 33.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 22 | $4,004 | $1,550 | 38.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 107 | 306 | $103,428 | $37,433 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 61 | 118 | $29,618 | $9,435 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 46 | 46 | $22,126 | $7,002 | 31.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 37 | $17,982 | $6,034 | 33.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 23 | $3,979 | $1,468 | 36.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 11 | $2,750 | $1,008 | 36.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 97 | 270 | $91,260 | $35,509 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 76 | 214 | $53,714 | $18,346 | 34.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 42 | 42 | $20,257 | $7,023 | 34.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 27 | $13,122 | $4,782 | 36.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 73 | $12,629 | $4,769 | 37.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 30 | $7,500 | $2,815 | 37.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 70 | 230 | $29,670 | $9,451 | 31.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 49 | 91 | $22,841 | $6,274 | 27.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 32 | 32 | $15,392 | $4,608 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 20 | 21 | $10,192 | $3,628 | 35.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 14 | 16 | $5,408 | $1,540 | 28.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 23 | $3,979 | $1,496 | 37.6% |
About Dr. Suthee Rapisuwon, M.D
Dr. Suthee Rapisuwon, M.D is a Clinical Genetics (M.D.) healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275723199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suthee Rapisuwon, M.D has received a total of $3,091 in payments from pharmaceutical and medical device companies, with $218.72 received in 2024. These payments were reported across 21 transactions from 10 companies. The most common payment nature is "Travel and Lodging" ($1,948).
As a Medicare-enrolled provider, Rapisuwon has provided services to 1,120 Medicare beneficiaries, totaling 2,271 services with total Medicare billing of $235,597. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Genetics (M.D.)
- Other Specialties Hematology & Oncology
- Location Washington, DC
- Active Since 07/26/2007
- Last Updated 11/23/2017
- Taxonomy Code 207SG0201X
- Entity Type Individual
- NPI Number 1275723199
Products in Payments
- KEYTRUDA (Biological) $1,672
- Rubraca (Drug) $601.03
- PROLEUKIN (Drug) $157.40
- Proleukin (Drug) $145.00
- LORBRENA (Drug) $135.00
- KIMMTRAK (Drug) $61.98
- MEKINIST (Drug) $28.75
- Padcev (Drug) $22.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Genetics (M.D.) Doctors in Washington
Dr. Nicholas Ah Mew, Md, MD
Clinical Genetics (M.D.) — Payments: $178,796
Clinical Genetics (M.D.) $178,796
Dr. Christina Grant, M.d., Ph.d, M.D., PH.D
Clinical Genetics (M.D.) — Payments: $49,719
Clinical Genetics (M.D.) $49,719
Mendel Tuchman, Md, MD
Clinical Genetics (M.D.) — Payments: $32,500
Clinical Genetics (M.D.) $32,500
Kenneth Rosenbaum, Md, MD
Clinical Genetics (M.D.) — Payments: $17,000
Clinical Genetics (M.D.) $17,000
Kimberly Chapman, M.d, M.D
Clinical Genetics (M.D.) — Payments: $3,268
Clinical Genetics (M.D.) $3,268
Dr. Susan Black, Md, MD
Clinical Genetics (M.D.) — Payments: $2,008
Clinical Genetics (M.D.) $2,008